Sell Before the Cliff: A Business Development Playbook for Sterile Manufacturing Suppliers Targeting Biologic LOE
Biologics don’t just “end”—they cliff. And when loss of exclusivity (LOE) hits, the market doesn’t politely wait for your pipeline to catc…
Generic competition isn’t just a legal event—it’s a business strategy.
For years, the industry narrative has been simple: once a patent expires, generics arrive, prices fall, and the market resets. But the real story—especially in branded pharmaceuti…
Patients don’t ask “What’s the patent status?”—they ask, “Will I be able to get my medicine tomorrow?”
That’s the real subtext behind the growing wave of online questions about drug switching. And it’s why the conversation around patents, exclusivity, …
Drug Switching Questions: What Patients Are Really Asking Online Read Post »
Evergreen strategies aren’t new—but the playbook is getting faster, smarter, and harder to see.
For pharma teams, the real risk isn’t just that a brand files another patent. It’s that the brand files the right kind of patent—at the right time—using the…
Pfizer’s Keytruda, also known as pembrolizumab, received initial FDA approval on September 4, 2014, for use in treating… https://www.Drugchatter.com/chat/37536/can-you-recall-the-initial-fda-approval-year-for-keytruda/
DrugChatter: Can you recall the initial fda approval year for keytruda? Read Post »
Research suggests that aspirin may interact with icosapent ethyl, the active ingredient in Vascepa, a prescription omega-3… https://www.Drugchatter.com/chat/12502/can-aspirin-interfere-with-vascepa’s-effectiveness/
DrugChatter: Can aspirin interfere with vascepa’s effectiveness? Read Post »
Research suggests that aspirin may interact with icosapent ethyl, the active ingredient in Vascepa, a prescription omega-3… https://www.Drugchatter.com/chat/12502/can-aspirin-interfere-with-vascepa’s-effectiveness/
DrugChatter: Can aspirin interfere with vascepa’s effectiveness? Read Post »
Research suggests that aspirin may interact with icosapent ethyl, the active ingredient in Vascepa, a prescription omega-3… https://www.Drugchatter.com/chat/12502/can-aspirin-interfere-with-vascepa’s-effectiveness/
DrugChatter: Can aspirin interfere with vascepa’s effectiveness? Read Post »
Research suggests that aspirin may interact with icosapent ethyl, the active ingredient in Vascepa, a prescription omega-3… https://www.Drugchatter.com/chat/12502/can-aspirin-interfere-with-vascepa’s-effectiveness/
DrugChatter: Can aspirin interfere with vascepa’s effectiveness? Read Post »
Research suggests that aspirin may interact with icosapent ethyl, the active ingredient in Vascepa, a prescription omega-3… https://www.Drugchatter.com/chat/12502/can-aspirin-interfere-with-vascepa’s-effectiveness/
DrugChatter: Can aspirin interfere with vascepa’s effectiveness? Read Post »
Get new actionable insights and updates from BiotechBlog
